Dr. Clemmons is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
101 Manning Dr
Chapel Hill, NC 27514Phone+1 919-966-8596Fax+1 919-843-5515
Summary
- Dr. David Clemmons is an endocrinologist in Chapel Hill, NC and is affiliated with University of North Carolina Hospitals. He received his medical degree from University of North Carolina at Chapel Hill School of Medicine and has been in practice 43 years. He specializes in diabetes, lipid metabolism, and pituitary disorders & neuroendocrinology.
Education & Training
- Massachusetts General HospitalResidency, Internal Medicine, 1977 - 1979
- Johns Hopkins UniversityResidency, Internal Medicine, 1976 - 1977
- Massachusetts General HospitalResidency, Internal Medicine, 1974 - 1976
- University of North Carolina at Chapel Hill School of MedicineClass of 1974
Certifications & Licensure
- NC State Medical License 1974 - 2021
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Elected Member The American Society for Clinical Investigation, 1987
Publications & Presentations
PubMed
- 1 citationsIGF-I assay methods and biologic variability: evaluation of acromegaly treatment response.David R Clemmons, Martin Bidlingmaier
European Journal of Endocrinology. 2024-07-02 - 2 citationsInsights from an advisory board: Facilitating transition of care into adulthood in brain cancer survivors with acquired pediatric growth hormone deficiency.Craig Alter, Margaret Boguszewski, David Clemmons, Georgiana A Dobri, Mitchell E Geffner
Growth Hormone & IGF Research. 2024-02-01 - 3 citationsDevelopment of a Novel Algorithm to Identify People with High Likelihood of Adult Growth Hormone Deficiency in a US Healthcare Claims Database.Kevin C J Yuen, Anna Camilla Birkegard, Lewis S Blevins, David R Clemmons, Andrew R Hoffman
International Journal of Endocrinology. 2022-01-01
Journal Articles
- A Consensus Statement on Acromegaly Therapeutic OutcomesDavid R Clemmons, Shlomo Melmed, Anne Klibanski, Nature
Lectures
- VPI-2690B, a Novel Alphavbeta3 Integrin Antibody, Reduces Hyperglycemia-induced Changes in Renal Function in a Rat Model of Diabetic NephropathyChapel Hill, NC - 6/14/2014
Other
- Physiology of insulin-like growth factor IClemmons DR
http://www.uptodate.com/contents/physiology-of-insulin-like-growth-factor-i
UpToDate, Wolters Kluwer Health - 2012-05-22
Press Mentions
- The New Gender Rules in SportsOctober 15th, 2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: